At a glance
- Originator Tsumura
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action 12-lipoxygenase inhibitors; Aldehyde reductase inhibitors; Cyclooxygenase inhibitors; Peroxidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Diabetic complications
Most Recent Events
- 10 Apr 1997 Preclinical development for Cancer in Japan (PO)
- 14 Oct 1994 Preclinical development for Diabetic complications in Japan (PO)